Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer

Clinical trial NCT00316173 · COMPLETED

Trial details

NCT number: NCT00316173
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Neoplasms, Ovarian

Start date: 2005-03-01
Primary completion: 2009-01-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.